Structure-Based Approach for the Discovery of Pyrrolo[3,2-<i>d</i>]pyrimidine-Based EGFR T790M/L858R Mutant Inhibitors
Satoshi Sogabe(Takeda (Japan)), Tomoyasu Ishikawa(Takeda (Japan)), S. Igaki(Takeda (Japan)), Youichi Kawakita(Takeda (Japan)), Hidehisa Iwata(Takeda (Japan)), Shinji Takagi(Takeda (Japan)), Hiroshi Miki(Takeda (Japan)), Douglas R. Cary(Takeda (Japan)), Yoshikazu Ohta(University of Miyazaki), Terufumi Takagi(Takeda (Japan))
Cited by 171
Related Papers
Structural Analysis of the Mechanism of Inhibition and Allosteric Activation of the Kinase Domain of HER2 Protein
|Journal of Biological Chemistry|2011|441
Design and Synthesis of Novel Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual Inhibitors Bearing a Pyrrolo[3,2-<i>d</i>]pyrimidine Scaffold
|Journal of Medicinal Chemistry|2011|223
JARID1B Is a Luminal Lineage-Driving Oncogene in Breast Cancer
|Cancer Cell|2014|208
Studies on Disease-Modifying Antirheumatic Drugs: Synthesis of Novel Quinoline and Quinazoline Derivatives and Their Anti-inflammatory Effect
|Journal of Medicinal Chemistry|1996|151
Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: Effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys
|The Journal of Steroid Biochemistry and Molecular Biology|2012|116